Indication
Details coming soon
Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Asthma Age: Adult |
Dose: Inhalation Powder – salmeterol 50 mcg and fluticasone propionate 100/250/500 mcg/dose Frequency: 1 inhalation twice daily |
|
Indication: Asthma Age: Adult |
Dose: Pressurised Inhalation – salmeterol 25 mcg and fluticasone propionate 50/125/250 mcg/dose Frequency: 2 inhalation twice daily |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Asthma Age: 4-12 years |
Dose: Inhalation Powder – salmeterol 50 micrograms and fluticasone propionate 100 micrograms/dose Frequency: 1 inhalation twice daily |
|
Indication: Asthma Age: 4-12 years |
Dose: Pressurised Inhalation – salmeterol 25 micrograms and fluticasone propionate 50 micrograms/dose Frequency: 2 inhalation twice daily |
Administration
- Inhale twice daily
- Rinse mouth after use
Side Effect
- Upper respiratory tract infection (URTI) (21-27%)
- Headache (12-21%)
- Pharyngitis (10-13%)
- Candidiasis
- nonspecific site (0-10%)
- Throat irritation (7-9%)
- Musculoskeletal pain (2-9%)
- Bronchitis (2-8%)
- Upper respiratory inflammation (4-7%)
- Viral respiratory infections (4-6%)
- Nausea or vomiting (4-6%)
- Cough (3-6%)
- Sinusitis (4-5%)
- Hoarseness or dysphonia (2-5%)
- Fever (3-4%)
- Diarrhea (2-4%)
- Gastrointestinal (GI) discomfort or pain (1-4%)
- Oral candidiasis (1-4%)
- Muscle cramps or spasms (3%)
- Malaise or fatigue (2-3%)
- Viral GI infections (0-3%)
- Paradoxical bronchospasm
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Ritonavir, Ketoconazole, Itraconazole
|
Increased fluticasone levels
|
|
Other beta-agonists
|
Additive effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Status Asthmaticus
|
Not effective for emergency treatment
|
|
Severe Milk Protein Hypersensitivity
|
Risk of severe allergic reaction
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Pressurised canister, do not puncture, break or incinerate even when apparently empty. Avoid storage in direct sunlight or heat. Store below 30°C. Keep away from eyes. Keep away from children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.